Advances in multiparametric MRI combined with improved sampling by MR/TRUS fusion-guided prostate biopsy (FBx) have resulted in rapid adoption of this novel technology into the biopsy paradigm. FBx accuracy is dependent on a number of factors and acquired skills that vary by user experience. We aim to define the differences among users with varying levels of experience with a tracked fusion biopsy platform.